Jianan Hui

Dr. Jianan Hui


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2021 in Biosensors
Verified
Journal Article
Open access
PDF file
BLBo Lin
Bo Lin
JHJianan Hui
Jianan Hui
Hongju MaoHongju Mao
Hongju Mao
In recent years, nanopore technology has become increasingly important in the field of life science and biomedical research. By embedding a nano-scale hole in a thin membrane and measuring the electrochemical signal, nanopore technology can be used to investigate the nucleic acids and other biomacromolecules. One of the most successful applications of nanopore technology, the Oxford Nanopore Technology, marks the beginning of the fourth generation of gene sequencing technology. In this review, the operational principle and the technology for signal processing of the nanopore gene sequencing are documented. Moreover, this review focuses on the applications using nanopore gene sequencing technology, including the diagnosis of cancer, detection of viruses and other microbes, and the assembly of genomes. These applications show that nanopore technology is promising in the field of biological and biomedical sensing.

27 May 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
ZLZening Li
Zening Li
JHJianan Hui
Jianan Hui
PYPanhui Yang
Panhui Yang
Hongju MaoHongju Mao
Hongju Mao
An organ-on-a-chip is a device that combines micro-manufacturing and tissue engineering to replicate the critical physiological environment and functions of the human organs. Therefore, it can be used to predict drug responses and environmental effects on organs. Microfluidic technology can control micro-scale reagents with high precision. Hence, microfluidics have been widely applied in organ-on-chip systems to mimic specific organ or multiple organs in vivo. These models integrated with various sensors show great potential in simulating the human environment. In this review, we mainly introduce the typical structures and recent research achievements of several organ-on-a-chip platforms. We also discuss innovations in models applied to the fields of pharmacokinetics/pharmacodynamics, nano-medicine, continuous dynamic monitoring in disease modeling, and their further applications in other fields.

23 August 2023 in Chemosensors
Verified
Journal Article
Open access
PDF file
ZXZhe Xing
Zhe Xing
JHJianan Hui
Jianan Hui
BLBo Lin
Bo Lin
ZWZhenhua Wu
Zhenhua Wu
Hongju MaoHongju Mao
Hongju Mao
Sweat, as a biofluid that is easy to extract and contains a variety of biomarkers, can provide various types of physiological information for health monitoring. In recent years, research on wearable sensors for sweat sensing has been emerging continuously. Wearable sweat sensing will probably become an alternative method to traditional chemical analysis. This is due to its advantages of portability, non-invasiveness, comfort, and continuous monitoring. Since the inception of this research field, wearable sweat sensors have achieved significant development in terms of materials, structures, systems, and application directions. Research interests are gradually evolving from single biomarker detection to the pursuit of multi-channel, multi-modal system-level architecture. The analysis of physiological signals has also developed from single signal characterization to omics analysis using multiple physiological information sources. Based on the changes mentioned above, this paper mainly introduces the latest researches of wearable sweat sensors from the aspects of strategy, architecture, material, system, data processing, etc., and tries to summarize the trends of sweat sensors. Finally, this paper analyzes the challenges faced by the sensing platform and possible methods for optimization.

30 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
PZPengcheng Zhao
Pengcheng Zhao
JWJieyu Wang
Jieyu Wang
Hongju MaoHongju Mao
Hongju Mao
LZLin Zhou
Lin Zhou
ZWZhenhua Wu
Zhenhua Wu
GMGuowu Ma
Guowu Ma
Alzheimer’s disease (AD) early screening requires non-invasive, high-sensitivity detection of low-abundance biomarkers in complex biofluids like saliva. In this study, we present a miniaturized, silicon-based electrochemical sensor for sequential detection of two AD salivary biomarkers, lactoferrin (Lf) and amyloid β-protein 1-42 (Aβ1-42), on a single reusable electrode. The sensor features a three-electrode system fabricated by sputter-coating a quartz substrate with gold (Au) sensing electrodes, which are further modified with gold nanoparticles (AuNPs) to form 3D dendritic structures that enhance surface area and electron transfer. To improve specificity, immunomagnetic beads (MBs) are employed to selectively capture and isolate target biomarkers from saliva samples. These MB–biomarker complexes are introduced into a polydimethylsiloxane chamber aligned with Au sensing electrodes, where a detachable magnet localizes the complexes onto the electrode surface to amplify redox signals. The AuNPs/MBs sensor achieves detection limits of 2 μg/mL for Lf and 0.1 pg/mL for Aβ1-42, outperforming commercial ELISA kits (37.5 pg/mL for Aβ1-42) and covering physiological salivary concentrations. After the MBs capture the biomarkers, the sensor can output the result within one minute. Cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) measurements confirm enhanced electron transfer kinetics on AuNP-decorated surfaces, while linear correlations (R2 > 0.95) validate quantitative accuracy across biomarker ranges. The compact and integrated design eliminates reliance on bulky instrumentation and enables user-friendly operation, establishing a promising platform for portable, cost-effective AD screening and monitoring.

24 October 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
YLYunxing Lu
Yunxing Lu
WZWenjing Zhang
Wenjing Zhang
QSQiang Shi
Qiang Shi
JHJianan Hui
Jianan Hui
JWJieyu Wang
Jieyu Wang
XYXiaoyue Yang
Xiaoyue Yang
While immune escape and physical invasion are two key pathways in tumor development, traditional methods for analyzing their exosomal markers are often complex and face identification bias. Microfluidic technology offers significant advantages for non-invasive liquid biopsy, particularly in the analysis of tumor progression markers carried by exosomes. Here, we developed an integrated microfluidic system for the sensitive, accurate, totally on-chip exosome isolation and automatic quantification of tumor progression markers PD-L1 and MMP9. This platform leverages microfluidic design principles for efficient sample mixing and monodisperses microbeads for precise analysis, allowing for complete processing within 40 min. The system’s high efficiency and precision are further enhanced by a lightweight YOLOv5-based positional migration strategy that automates fluorescence quantification. Validation using four different cell lines demonstrated distinct exosomal protein signatures with a low detection limit of 12.58 particles/μL. This innovative microfluidic chip provides a sensitive and easy-to-handle tool for exosomal marker analysis, holding great potential for cancer identification and personalized therapy guidance in the era of point-of-care testing (POCT).